| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/17/2010 | US20100152274 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester |
| 06/17/2010 | US20100152271 Estrogen receptor modulators and uses thereof |
| 06/17/2010 | US20100152261 Novel nitrogen-containing heterocyclic compound |
| 06/17/2010 | US20100152259 Angiotensin ii receptor antagonists |
| 06/17/2010 | US20100152258 Angiotensin ii receptor antagonists |
| 06/17/2010 | US20100152257 Antagonists of lysophosphatidic acid receptors |
| 06/17/2010 | US20100152255 Organic Compounds |
| 06/17/2010 | US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
| 06/17/2010 | US20100152248 Ischemic disorder or disease inhibitors |
| 06/17/2010 | US20100152246 5-Oxoisoxazoles as inhibitors of lipases and phospholipases |
| 06/17/2010 | US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 06/17/2010 | US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 06/17/2010 | US20100152210 Purinyl derivatives and their use as potassium channel modulators |
| 06/17/2010 | US20100152208 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/17/2010 | US20100152187 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
| 06/17/2010 | US20100152186 Triazolyl pyridyl benzenesulfonamides |
| 06/17/2010 | US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 06/17/2010 | US20100152178 Imidazole derivatives |
| 06/17/2010 | US20100152176 Modulators of Muscarinic Receptors |
| 06/17/2010 | US20100152171 CGRP Antagonists |
| 06/17/2010 | US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 06/17/2010 | US20100152167 Pyrimidine derivatives |
| 06/17/2010 | US20100152156 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases |
| 06/17/2010 | US20100152153 Nitric Oxide Releasing Compounds |
| 06/17/2010 | US20100152151 Tgr5 modulators and methods of use therof |
| 06/17/2010 | US20100152150 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 06/17/2010 | US20100152144 Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease |
| 06/17/2010 | US20100152118 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/17/2010 | US20100152117 Aequorin-Containing Compositions and Methods of Using Same |
| 06/17/2010 | US20100152113 Metal-binding therapeutic peptides |
| 06/17/2010 | US20100152112 Quinoline derivatives as p13 kinase inhibitors |
| 06/17/2010 | US20100152111 Polymer-based sustained release device |
| 06/17/2010 | US20100152105 Use of rapamycin derivatives in chronic rejection |
| 06/17/2010 | US20100152100 Accelerated therapy |
| 06/17/2010 | US20100151063 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level |
| 06/17/2010 | US20100151042 Materials and Methods for Treating Influenza Infections |
| 06/17/2010 | US20100151019 SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS WITH POOR AQUEOUS SOLUBILITY AT LOW pH AND METHODS OF USE THEREOF |
| 06/17/2010 | US20100151011 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
| 06/17/2010 | US20100151007 Compositions and methods for selective inhibition of vegf |
| 06/17/2010 | US20100151002 Guggulphospholipid Methods and Compositions |
| 06/17/2010 | US20100150970 Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction |
| 06/17/2010 | US20100150937 Antagonists of pcsk9 |
| 06/17/2010 | US20100150913 Organic compounds |
| 06/17/2010 | US20100150899 Pyrazolinone scavengers of free radical |
| 06/17/2010 | US20100150893 Methods of organ regeneration |
| 06/17/2010 | US20100150887 Tissue Progenitor Cells That Overexpress ERG |
| 06/17/2010 | US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases |
| 06/17/2010 | US20100150860 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof |
| 06/17/2010 | US20100150837 ANTIBODIES AGAINST GPIb alpha |
| 06/17/2010 | DE102008062567A1 Dipeptoid-Prodrugs und ihre Verwendung Dipeptoid prodrugs and their use |
| 06/17/2010 | DE102008062566A1 Aminosäureester-Prodrugs und ihre Verwendung Amino acid ester prodrugs and their use |
| 06/17/2010 | DE102008062136A1 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk |
| 06/17/2010 | CA2747279A1 3,4 - substituted piperidine derivatives as renin inhibitors |
| 06/17/2010 | CA2746457A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke |
| 06/17/2010 | CA2746422A1 Kinase inhibitor compounds |
| 06/17/2010 | CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines |
| 06/17/2010 | CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 06/17/2010 | CA2743768A1 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease |
| 06/16/2010 | EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 06/16/2010 | EP2196212A1 Preparation and method of administering vaccine and iontophoresis device using the preparation |
| 06/16/2010 | EP2195328A1 Certain chemical entities, compositions, and methods |
| 06/16/2010 | EP2195292A1 Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer |
| 06/16/2010 | EP2195014A2 Use of g-csf for the treatment of stroke |
| 06/16/2010 | EP2195012A2 Use of a peptide as a therapeutic agent |
| 06/16/2010 | EP2194975A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-ß DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 06/16/2010 | EP1863802B1 Substituted piperidines as renin inhibitors |
| 06/16/2010 | EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 06/16/2010 | EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine |
| 06/16/2010 | CN1985909B Medicine for hyperlipemia and its production process |
| 06/16/2010 | CN1965933B Medicated tea for lowering blood pressure and method for preparing same |
| 06/16/2010 | CN1946426B Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof |
| 06/16/2010 | CN1895318B Use of pepperweed seed in preparation of medicine for preventing and treating myocardial hypertrophia or/and ventricular hypertrophy |
| 06/16/2010 | CN1889949B PDK-1/Akt signaling inhibitors |
| 06/16/2010 | CN1886141B T-type calcium channel inhibitor |
| 06/16/2010 | CN1883541B A Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease, its preparation method and use |
| 06/16/2010 | CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof |
| 06/16/2010 | CN1774428B M-stage kinesin inhibitor |
| 06/16/2010 | CN1526409B Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
| 06/16/2010 | CN1518558B Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 06/16/2010 | CN1517126B Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 06/16/2010 | CN1500095B Polymer conjugates of neublastin and methods of using ssame |
| 06/16/2010 | CN1393446B 稠合吡唑化合物 Fused pyrazole compounds |
| 06/16/2010 | CN101743228A Process for preparing telmisartan |
| 06/16/2010 | CN101743001A Combination anticoagulant therapy with a compound that acts as a factor xa inhibitor |
| 06/16/2010 | CN101735923A Health care wine for eliminating sub-health |
| 06/16/2010 | CN101735918A Selenium-rich health wine and production method thereof |
| 06/16/2010 | CN101735307A Platelet envelope glycoprotein oligopeptide or trim/derivate thereof and application thereof |
| 06/16/2010 | CN101735305A Synthesizing method of L-carnosine |
| 06/16/2010 | CN101735276A Water-soluble phosphate monoester derivatives and application thereof |
| 06/16/2010 | CN101735230A Bisbenzylisoquinoline derivative and preparation and application thereof |
| 06/16/2010 | CN101735221A Diaryl-1,2,4-triazole [4,3-a] pyrimidine heterocyclic compound, preparation method and application thereof |
| 06/16/2010 | CN101735212A Controlled synthesis of ziprasidone and compositions thereof |
| 06/16/2010 | CN101735206A Crystalline form IV of azimilide dihydrochloride, preparation method and application thereof |
| 06/16/2010 | CN101735205A Crystalline form V of azimilide dihydrochloride, preparation method and application thereof |
| 06/16/2010 | CN101735204A Crystalline form III of azimilide dihydrochloride, preparation method and application thereof |
| 06/16/2010 | CN101735203A Azimilide dihydrochloride crystal form II as well as preparation method and application thereof |
| 06/16/2010 | CN101735202A Azimilide dihydrochloride crystal form I as well as preparation method and application thereof |
| 06/16/2010 | CN101735172A Cinepazide monohydrate, crystal forms and preparation method thereof |
| 06/16/2010 | CN101735136A Metal ion complex salt with vitamin F serving as active ingredient, oral solid preparation and lyophilized injection |
| 06/16/2010 | CN101735131A New salts |